Coffee Holding Co. reported a strong third-quarter earnings per share of $0.35, far surpassing analyst expectations, signaling robust profitability. However, revenue declined to $21.69 million, missing estimates due to falling green coffee prices and a 9.3% year-over-year sales decrease. The company responded by lowering prices to customers, reflected in a low Price-to-Sales ratio of 0.22. Financially, Coffee Holding remains stable with a low Debt-to-Equity ratio of 0.16 and a strong current ratio of 3.62, indicating solid liquidity and low reliance on debt.
Visa Canada's data reveals that the Toronto International Film Festival (TIFF) 2026 increased visitor spending by 12% compared to 2025, with international visitors spending about 40% more than Canadian cardholders. The festival attracted visitors mai...
Aclarion, Inc. has updated the enrollment criteria for its CLARITY clinical trial to better reflect real-world chronic low back pain patients and accelerate patient recruitment. The revised criteria, approved at most active sites, expand the pool of ...
Zscaler CEO Jay Chaudhry has sold 2,852 shares of the company, generating $550,000 from the transaction. This sale could indicate personal financial planning or portfolio rebalancing by the CEO. Investors might watch for any further insider activity ...
Ascentis Independent Advisors has expanded by adding four advisory teams from Raymond James Financial Services, bringing over $1 billion in client assets. These teams, based in California and Colorado, chose Ascentis to access enhanced planning, inve...
Filament Health, a subsidiary of Rhelion Life Sciences, will supply its patented psilocybin drug candidate PEX010 to a University of California, San Francisco (UCSF) Phase 2 clinical trial. The trial, starting November 2026, will test whether a singl...
